Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies

Pancreatic ductal adenocarcinoma (PDAC), which constitutes 90% of pancreatic cancers, is the fourth leading cause of cancer-related deaths in the world. Due to the broad heterogeneity of genetic mutations and dense stromal environment, PDAC belongs to one of the most chemoresistant cancers. Most of...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamska, Aleksandra, Domenichini, Alice, Falasca, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535831/
https://www.ncbi.nlm.nih.gov/pubmed/28640192
http://dx.doi.org/10.3390/ijms18071338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535831/
https://www.ncbi.nlm.nih.gov/pubmed/28640192
http://dx.doi.org/10.3390/ijms18071338

Ejemplares similares